Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-10-01

Clinical Trial Update: The Moran AMD Genetic Testing Assessment Study [Phase 2]

View source ↗

Summary

Phase 2 study update on Moran AMD Genetic Testing Assessment, evaluating genetic testing and nutritional biomarkers in age-related macular degeneration; results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Paul S. Bernstein | Conditions: Age-Related Macular Degeneration, Genetic Testing | Phase 2 | Status: COMPLETED | Results posted: 2025-10-01